CMS reinstates enforcement discretion under CLIA for certain SARS-CoV-2 tests
During the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, the Centers for Medicare & Medicaid Services announced Friday. The decision rescinds a Sept. 26 memorandum that ended the 2020 enforcement discretion policy.
Related News Articles
Headline
The South Carolina Department of Public Health March 6 reported that the state’s measles outbreak is at 991 cases. The agency said the vaccination status of…
Headline
The South Carolina Department of Public Health reported Feb. 27 that the state’s measles outbreak is at 985 cases, up six cases from Feb. 24. Nationally, there…
Headline
The Centers for Disease Control and Prevention Feb. 26 announced that an infant botulism outbreak that sickened 48 babies who consumed ByHeart formula is over…
Headline
The measles outbreak in South Carolina has increased to 979 cases, the state’s Department of Public Health reported Feb. 24. The agency said there have been 21…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The ongoing measles outbreak in South Carolina has reached 973 cases, the state’s Department of Public Health reported Feb. 20. Of those, 906 cases are…